1. Home
  2. DNLI vs PAX Comparison

DNLI vs PAX Comparison

Compare DNLI & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • PAX
  • Stock Information
  • Founded
  • DNLI 2013
  • PAX 1988
  • Country
  • DNLI United States
  • PAX Cayman Islands
  • Employees
  • DNLI N/A
  • PAX N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • PAX Investment Managers
  • Sector
  • DNLI Health Care
  • PAX Finance
  • Exchange
  • DNLI Nasdaq
  • PAX Nasdaq
  • Market Cap
  • DNLI 2.1B
  • PAX 1.8B
  • IPO Year
  • DNLI 2017
  • PAX 2021
  • Fundamental
  • Price
  • DNLI $12.29
  • PAX $11.41
  • Analyst Decision
  • DNLI Strong Buy
  • PAX Strong Buy
  • Analyst Count
  • DNLI 16
  • PAX 1
  • Target Price
  • DNLI $37.57
  • PAX $14.00
  • AVG Volume (30 Days)
  • DNLI 1.3M
  • PAX 528.1K
  • Earning Date
  • DNLI 05-06-2025
  • PAX 05-01-2025
  • Dividend Yield
  • DNLI N/A
  • PAX 5.28%
  • EPS Growth
  • DNLI N/A
  • PAX N/A
  • EPS
  • DNLI N/A
  • PAX 0.48
  • Revenue
  • DNLI N/A
  • PAX $374,200,000.00
  • Revenue This Year
  • DNLI N/A
  • PAX $6.32
  • Revenue Next Year
  • DNLI $373.37
  • PAX $3.91
  • P/E Ratio
  • DNLI N/A
  • PAX $23.78
  • Revenue Growth
  • DNLI N/A
  • PAX 14.22
  • 52 Week Low
  • DNLI $12.05
  • PAX $10.50
  • 52 Week High
  • DNLI $33.33
  • PAX $14.77
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 29.24
  • PAX 46.60
  • Support Level
  • DNLI $13.67
  • PAX $11.12
  • Resistance Level
  • DNLI $14.84
  • PAX $11.98
  • Average True Range (ATR)
  • DNLI 0.81
  • PAX 0.28
  • MACD
  • DNLI 0.03
  • PAX -0.00
  • Stochastic Oscillator
  • DNLI 5.84
  • PAX 50.43

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About PAX Patria Investments Limited

Patria Investments Ltd is a private markets investment firm. It seeks to provide global and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns.

Share on Social Networks: